USPTO serial 87782084
MORE THAN SCLERODERMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 6, 2018
- Examiner
- CHANG, ELIZABETH YI HSUAN
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with MORE THAN SCLERODERMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT
Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott J. Major
Scott J. Major MILLEN WHITE ZELANO & BRANIGAN, PC2200 CLARENDON BLVD., 14TH FLOORARLINGTON, VA 22201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting awareness of scleroderma, its symptoms, detection, prevention and treatment | ACTIVE | Feb 16, 2018 |
| 044 | Providing information on scleroderma, its symptoms, detection, prevention and treatment, including medical information on patients living with the disease | ACTIVE | Feb 16, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks owned by Boehringer Ingelheim Pharmaceuticals, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named MORE THAN SCLERODERMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 13, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 13, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 2, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 6, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 2, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 1, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 28, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 27, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 5, 2018 | IUAF | USE AMENDMENT FILED | — |
| Sep 5, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 4, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 10, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 10, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 6, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 18, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 18, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 18, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 18, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 18, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 16, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 13, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2018 | NWAP | NEW APPLICATION ENTERED | — |